Monitoring and tracking your progress Objective tracking eliminates guesswork and provides the data needed for informed protocol adjustments
The risk of reduced potency or contamination is not worth the savings from squeezing out a few extra doses
Em nota ao g1 , a Anvisa informa que os produtos que se apresentam como peptdeos denominados GHK-CU, BPC-157, TB500, CJC-1295 e Ipamorelina, que prometem melhoras estticas, no se encontram registrados perante a agncia
Tesamorelin is a synthetic modified GHRH analogue clinically approved to reduce visceral adipose tissue (VAT), especially in HIV-associated lipodystrophy, with demonstrated drops in VAT of ~15-18% over 52 weeks
We highly recommend the use of PRP before starting the BPC, as this combination/timeline of care has yielded the most promising results